Literature DB >> 16043291

Passive coping is a risk factor for disabling neck or low back pain.

Annalyn C Mercado1, Linda J Carroll, J David Cassidy, Pierre Côté.   

Abstract

BACKGROUND: Despite evidence suggesting that coping is an important concept in the study of pain, its role in predicting the development of disabling pain has not been previously studied. To assess the relationship between coping and the development of disabling pain.
METHODS: From a random sample of adults, we formed a cohort of individuals with non-disabling neck and/or low back pain (n=571). Participants were followed 6 and 12 months after the index survey. Coping was measured with the Vanderbilt Pain Management Inventory. The Chronic Pain Questionnaire was used to measure the presence of disabling neck and/or low back pain. We used Cox proportional hazards regression analyses to investigate the role of passive coping in the development of disabling pain while controlling for confounders.
RESULTS: Passive coping was a strong, independent risk factor for disabling neck and/or back pain. Those using moderate to high levels of passive coping strategies were at an over five-fold increased risk of developing disabling pain (Moderate: HRR=5.19, 95% CI=1.78-15.1; High: HRR=6.80, 95% CI=2.36-19.6). Active coping was not found to be a significant risk factor for disabling neck and/or back pain.
CONCLUSION: Passive coping is a strong and independent predictor of disabling neck and/or back pain. This strong relationship identifies passive coping as a marker for risk of disability and can allow for the identification of individuals at risk and in need of intervention to aid in improving their overall adjustment.

Entities:  

Mesh:

Year:  2005        PMID: 16043291     DOI: 10.1016/j.pain.2005.05.014

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  30 in total

Review 1.  Pain assessment.

Authors:  Mathias Haefeli; Achim Elfering
Journal:  Eur Spine J       Date:  2005-12-01       Impact factor: 3.134

2.  An experimental investigation of the relationships among race, prayer, and pain.

Authors:  Samantha M Meints; Catherine Mosher; Kevin L Rand; Leslie Ashburn-Nardo; Adam T Hirsh
Journal:  Scand J Pain       Date:  2018-07-26

3.  Attachment and adjustment in adolescents and young adults with a history of pediatric functional abdominal pain.

Authors:  Kelsey T Laird; Kristopher J Preacher; Lynn S Walker
Journal:  Clin J Pain       Date:  2015-02       Impact factor: 3.442

4.  Cross-cultural adaptation and validation of a Brazilian Portuguese version of the chronic pain grade.

Authors:  Eduardo S B Bracher; Ricardo Pietrobon; José Eluf-Neto
Journal:  Qual Life Res       Date:  2010-03-28       Impact factor: 4.147

5.  What lies beyond the pain? A case report.

Authors:  Mohd Hashim Syahnaz; Muhammad Noor Azimah; Omar Khairani
Journal:  Ment Health Fam Med       Date:  2010-12

6.  Open-space forced swim model of depression for mice.

Authors:  Eric A Stone; Yan Lin
Journal:  Curr Protoc Neurosci       Date:  2011-01

7.  Pediatric Pain Beliefs Questionnaire: Psychometric Properties of the Short Form.

Authors:  Amanda L Stone; Lynn S Walker; Kelsey T Laird; Kezia C Shirkey; Craig A Smith
Journal:  J Pain       Date:  2016-06-27       Impact factor: 5.820

8.  Evaluation of the repeated open-space swim model of depression in the mouse.

Authors:  Eric A Stone; Yan Lin; David Quartermain
Journal:  Pharmacol Biochem Behav       Date:  2008-07-19       Impact factor: 3.533

Review 9.  Back pain in osteoporotic vertebral fractures.

Authors:  R M Francis; T J Aspray; G Hide; A M Sutcliffe; P Wilkinson
Journal:  Osteoporos Int       Date:  2007-12-11       Impact factor: 4.507

10.  Designing a workplace return-to-work program for occupational low back pain: an intervention mapping approach.

Authors:  Carlo Ammendolia; David Cassidy; Ivan Steensta; Sophie Soklaridis; Eleanor Boyle; Stephanie Eng; Hamer Howard; Bains Bhupinder; Pierre Côté
Journal:  BMC Musculoskelet Disord       Date:  2009-06-09       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.